Healthcare private equity showed strong resilience in 2020, with global buyout deal counts reaching a record high even as total deal value declined for the first time since 2015, partly due to the pandemic dampening large, high‑value transactions and pushing some major assets toward SPACs. Despite this dip, overall deal value remained solid, highlighting sustained investor confidence. Looking ahead, healthcare profit pools are expected to grow steadily over the next five years, supported by powerful structural trends such as aging populations, rising chronic disease, expanding income levels and access to care, and continued innovation in treatments and technology, even as pricing growth is likely to remain moderate amid rising valuations and competitive pressure.

Join for free to read